A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older

Type: Interventional

Intervention: Ad26.COV2.S Vaccine

Site and lead:

  • Manchester Royal Infirmary – Dr Stephen Hughes
  • Saint Mary’s Hospital – Dr Stephen Hughes
  • Royal Manchester Children’s Hospital – Dr Stephen Hughes

Patient group: SARS-CoV-2 seronegative adults